临床外科杂志 ›› 2026, Vol. 34 ›› Issue (6): 653-657.doi: 10.3969/j.issn.1005-6483.20250469

• 论著 • 上一篇    下一篇

肺癌组织USP10、USP28和USP35表达及其与临床病理特征和预后的关系

任海锋,张三红,杜磊,吴明君,党苗苗   

  1. 宝鸡第三医院呼吸与危重症医学科
  • 收稿日期:2025-05-08 出版日期:2026-08-18 发布日期:2026-08-18
  • 通讯作者: 党苗苗
  • 作者简介:任海锋,张三红,杜磊,吴明君,党苗苗
  • 基金资助:
    陕西省重点研发计划项目(2018SF-1019)

Study on the expression of USP10,USP28,and USP35 in lung cancer tissues and their relationship with clinical pathological characteristics and prognosis

REN Haifeng,ZHANG Sanhong,DU Lei,WU Mingjun,DANG Miaomiao   

  1. Department of Respiratory and Critical Care Medicine,Baoji Third Hospital
  • Received:2025-05-08 Online:2026-06-20 Published:2026-08-18

摘要: 目的 研究肺癌(LC)组织泛素特异性蛋白酶(USP)10、USP 28、USP 35表达及与临床病理特征和预后的关系。方法 选择宝鸡第三医院2018年6月~2021年6月收治的LC病人154例,术中收集其肿瘤组织及癌旁正常余肺组织(距肿瘤切缘≥2cm)。采用免疫组织化学法检测肿瘤组织及癌旁正常余肺组织中USP10、USP28、USP35表达情况,分析三者与LC临床病理特征的关系,比较未发生和发生复发/转移病人的USP10、USP28、USP35表达情况,采用Kaplan-Meier曲线分析USP10、USP28、USP35阴性/阳性表达组3年无病生存率。结果 癌旁正常余肺组织及LC组织中USP10阳性表达率分别为10.39%、63.64%,USP28阳性表达率分别为12.99%、71.43%,USP35阳性表达率分别为14.94%、66.88%,LC组织中USP10、USP28、USP35阳性表达率均显著高于癌旁正常余肺组织,差异有统计学意义(P<0.05)。相比于TNM分期Ⅰ+Ⅱ期、未发生淋巴结转移者,TNM分期ⅢA期、发生淋巴结转移者癌组织内USP10、USP28、USP35阳性表达率显著升高,差异有统计学意义(P<0.05)。154例病人中位随访时间为29.23个月,失访4例,完成随访150例,随访率为97.40%(150/154),其中发生复发/转移98例,因复发/转移而死亡75例,肿瘤复发/转移率为65.33%(98/150),无病生存率为34.67%(52/150)。Kaplan-Meier生存曲线分析显示,USP10、USP28、USP35阳性表达组3年无病生存率显著短于阴性表达组,差异有统计学意义(P<0.05)。发生复发/转移的病人癌组织中USP10、USP28、USP35阳性表达率相较于未发生复发/转移病人显著升高,差异有统计学意义(P<0.05)。结论 肺癌组织中USP10、USP28、USP35高表达与淋巴结转移、TNM分期高、3年无病生存率低有关。

关键词: 泛素特异性蛋白酶10; 泛素特异性蛋白酶28; 泛素特异性蛋白酶35; 肺癌; 临床病理特征; 预后

Abstract: Objective To investigate the expression of ubiquitin specific protease (USP) 10,28,and 35 in lung cancer (LC) tissues and their relationship with clinical pathological characteristics and prognosis. Methods 154 patients with LC admitted to Baoji Third Hospital from June 2018 to June 2021 were selected.During the operation,tumor tissue and normal residual lung tissue adjacent to the cancer (≥2 cm from the tumor margin) were collected.Immunohistochemistry was used to detect the expression of USP10,USP28,and USP35 in tumor tissue and normal residual lung tissue adjacent to the cancer.The relationship between the three and the clinical pathological characteristics of LC was analyzed.The expression of USP10,USP28,and USP35 in patients who did not experience recurrence/metastasis and those who experienced recurrence/metastasis were compared.Kaplan Meiercurves were used to analyze the 3-year disease-free survival rate of USP10,USP28,and USP35 negative/positive expression groups. Results The positive expression rates of USP10,USP28,and USP35 in the normal residual lung tissue and LC tissue adjacent to the cancer were 10.39% and 63.64%,12.99% and 71.43%,and 14.94% and 66.88%,respectively.The positive expression rates of USP10,USP28,and USP35 in LC tissue were significantly higher than those in the normal residual lung tissue adjacent to the cancer (P<0.05).Compared with TNM stage Ⅰ+Ⅱ and those without lymph node metastasis,the positive expression rates of USP10,USP28,and USP35 in cancer tissues of TNM stage Ⅲa and those with lymph node metastasis were significantly increased (P<0.05).The median follow-up time for 154 patients was 29.23 months,with 4 lost to follow-up and 150 completed follow-up,resulting in a follow-up rate of 97.40% (150/154).Among them,98 cases experienced recurrence/metastasis,and 75 cases died due to recurrence/metastasis.The tumor recurrence/metastasis rate was 65.33% (98/150),and the disease-free survival rate was 34.67% (52/150).Kaplan Meiersurvival curve analysis showed that the 3-year disease-free survival rate of the USP10,USP28,and USP35 positive expression groups was significantly shorter than that of the negative expression group (P<0.05).The positive expression rates of USP10,USP28,and USP35 in cancer tissues of patients with recurrence/metastasis were significantly higher than those of patients without recurrence/metastasis (P<0.05). Conclusion The high expression of USP10,USP28,and USP35 in lung cancer tissues is associated with lymph node metastasis,high TNM staging,and low 3-year disease-free survival rate.

Key words: ubiquitin specific protease 10; ubiquitin specific protease 28; ubiquitin specific protease 35; lung cancer; clinical and pathological features; prognosis

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 胡小平;王志维;邓宏平;等. 改良全主动脉弓置换治疗老年Stanford A型主动脉夹层[J]. 临床外科杂志, 2016, 24(10): 777 .
[2] 杨永辉;李欣欣;郝孟辉;等. 孤立性肺结节的诊治分析[J]. 临床外科杂志, 2016, 24(11): 856 .
[3] 周振宇;汪路明;王一青;等. 肺部多发结节468例诊疗分析[J]. 临床外科杂志, 2016, 24(11): 865 .
[4] 刘曦明;吴刚. 髋臼骨折前路内固定的研究进展[J]. 临床外科杂志, 2016, 24(5): 392 -0 .
[5] 丁锦辉;丁贺义;蒋米尔. 下肢深静脉血栓腔内治疗进展[J]. 临床外科杂志, 2016, 24(8): 638 .
[6] 吴超;汪全新;张保. 腹腔镜联合胆道镜经胆囊管汇入部微切开治疗胆囊结石合并胆总管结石52例[J]. 临床外科杂志, 2016, 24(8): 594 .
[7] 谭最. 下肢静脉曲张的诊疗分析[J]. 临床外科杂志, 2016, 24(8): 580 .
[8] 万春;万品文;戴兵. 陈氏双悬吊法在中肝叶肿瘤切除术中的应用[J]. 临床外科杂志, 2016, 24(8): 592 .
[9] 王荣平 朱水波 张晓明等. 手足多汗症外科治疗66例分析[J]. 临床外科杂志, 2016, 24(9): 726 .
[10] 洪德飞. 对传统胰消化道重建术理念与技术的反思与创新[J]. 临床外科杂志, 2017, 25(10): 731 -734 .